Return to content in this issue
Off-label Use of Mepolizumab: A Potential Therapeutic Option for Eosinophilic Cystitis
Wang G1 , Zhuo N2, Liu Z1
1Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, China
2Department of Nephrology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China
J Investig Allergol Clin Immunol 2024; Vol 34(4)
: 277-278
doi: 10.18176/jiaci.0973
Key words: Eosinophilic cystitis, Mepolizumab
| Title | Type | Size | |
|---|---|---|---|
 |
doi10.18176_jiaci.0973_supplemental-materials-table.pdf | 329.95 Kb |
